Lab
Core Analytics Laboratory, LLC
Core Analytics Laboratory, LLC was paid $1.92M by Medicaid between Jan 2018 and Sep 2024, across 101 billing codes. Its largest line is 85025, Blood count; complete (CBC), automated, and automated differential WBC count — 17% of everything it billed.
33Billing provider infoCORE ANALYTICS LABORATORY, LLC
VAN NUYS, CA 91411
VAN NUYS, CA 91411
33aNPI1003904673assigned 10/10/2006
33bProvider typeClinical Medical Laboratory
28Total paid$1.92M
24GClaims657,659
24DCodes billed101
24AFirst – last monthJan 2018 – Sep 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in California
Rank by total paid#151 of 561
Median peer was paid$222K
This provider vs. median8.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 92,963 | $189K | |
| 2019 | 103,433 | $252K | |
| 2020 | 68,699 | $292K | |
| 2021 | 71,349 | $235K | |
| 2022 | 89,534 | $306K | |
| 2023 | 167,820 | $465K | |
| 2024incomplete | 63,861 | $181K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 17% | 118,143 | 83,063 | $322K |
| 80053 | Comprehensive metabolic panel | 13% | 69,081 | 57,311 | $258K |
| 80048 | Basic metabolic panel (calcium, ionized) | 7.7% | 47,650 | 32,370 | $148K |
| 84443 | Thyroid stimulating hormone (TSH) | 6.4% | 23,491 | 21,937 | $122K |
| 82652 | 6.3% | 8,514 | 8,174 | $121K | |
| 80061 | Lipid panel | 4.9% | 22,715 | 21,727 | $93K |
| 83036 | Hemoglobin; glycosylated (A1C) | 4.9% | 28,042 | 26,275 | $93K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 2.6% | 18,243 | 15,918 | $50K |
| G0471 | Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) | 2.6% | 71,529 | 45,600 | $50K |
| 80164 | 2.1% | 8,314 | 7,471 | $41K | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 2.1% | 47,141 | 29,743 | $40K |
| 87088 | 1.6% | 12,245 | 11,320 | $32K |
89 more codes
| 84134 | 1.6% | 5,873 | $30K | |
| 83880 | 1.5% | 2,346 | $29K | |
| 87077 | 1.5% | 7,896 | $29K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 1.5% | 440 | $28K |
| 80177 | 1.4% | 4,100 | $27K | |
| 87186 | 1.3% | 8,686 | $26K | |
| 83735 | 1.3% | 10,204 | $25K | |
| 81001 | 1.2% | 20,539 | $23K | |
| 82140 | 1.2% | 4,220 | $23K | |
| 80185 | 1.1% | 3,179 | $22K | |
| 85610 | <1% | 13,659 | $18K | |
| 87070 | <1% | 4,282 | $16K | |
| 82607 | <1% | 4,372 | $15K | |
| 84100 | <1% | 6,904 | $14K | |
| 84439 | <1% | 5,217 | $13K | |
| 82746 | <1% | 3,245 | $13K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 297 | $12K |
| 82728 | <1% | 2,791 | $11K | |
| 83540 | <1% | 5,111 | $11K | |
| 80202 | <1% | 2,011 | $11K | |
| 83550 | <1% | 3,796 | $10K | |
| 86140 | <1% | 3,996 | $9K | |
| 84153 | <1% | 1,350 | $8K | |
| 80076 | <1% | 3,227 | $8K | |
| 87493 | <1% | 736 | $7K | |
| G2024 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source | <1% | 455 | $7K |
| 84481 | <1% | 1,191 | $6K | |
| 85014 | <1% | 5,330 | $5K | |
| 85018 | <1% | 5,369 | $5K | |
| 82274 | <1% | 1,107 | $5K | |
| 87040 | <1% | 887 | $5K | |
| 82248 | <1% | 2,995 | $5K | |
| 85651 | <1% | 3,513 | $4K | |
| 80150 | <1% | 444 | $4K | |
| 85004 | <1% | 1,453 | $4K | |
| 80178 | <1% | 1,491 | $4K | |
| 99000 | <1% | 1,236 | $4K | |
| 82805 | <1% | 232 | $4K | |
| 82040 | <1% | 2,306 | $4K | |
| 87184 | <1% | 2,309 | $4K | |
| 82565 | <1% | 1,823 | $3K | |
| 84436 | <1% | 1,580 | $3K | |
| 85049 | <1% | 1,525 | $3K | |
| 85730 | <1% | 1,502 | $3K | |
| 84132 | <1% | 1,460 | $2K | |
| 85041 | <1% | 1,430 | $2K | |
| 80162 | <1% | 633 | $2K | |
| 87324 | <1% | 481 | $2K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 40 | $2K |
| 84520 | <1% | 1,177 | $2K | |
| 84550 | <1% | 1,403 | $2K | |
| 84480 | <1% | 345 | $1K | |
| 82310 | <1% | 483 | $1K | |
| 84460 | <1% | 401 | $1K | |
| 84145 | <1% | 58 | $1K | |
| 87181 | <1% | 1,467 | $981.97 | |
| 80159 | <1% | 93 | $896.52 | |
| 82947 | <1% | 486 | $801.94 | |
| 84450 | <1% | 285 | $742.02 | |
| 82552 | <1% | 147 | $625.35 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 225 | $605.02 |
| 84479 | <1% | 311 | $595.47 | |
| 86592 | <1% | 271 | $570.13 | |
| 82378 | <1% | 116 | $552.25 | |
| 82043 | <1% | 311 | $534.37 | |
| 99001 | <1% | 1,641 | $415.01 | |
| 83690 | <1% | 188 | $410.11 | |
| 80156 | <1% | 78 | $382.63 | |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | <1% | 1,898 | $366.62 |
| 85048 | <1% | 519 | $351.89 | |
| 84295 | <1% | 177 | $338.02 | |
| 87045 | <1% | 104 | $295.17 | |
| 80184 | <1% | 58 | $252.63 | |
| 84075 | <1% | 85 | $241.43 | |
| 80051 | <1% | 71 | $238.46 | |
| 80069 | <1% | 91 | $234.99 | |
| 87220 | <1% | 133 | $225.81 | |
| 82435 | <1% | 103 | $199.69 | |
| 86803 | <1% | 17 | $175.46 | |
| 82247 | <1% | 63 | $161.32 | |
| 83615 | <1% | 63 | $159.95 | |
| 84155 | <1% | 86 | $154.35 | |
| 87449 | <1% | 34 | $148.73 | |
| 82150 | <1% | 81 | $145.85 | |
| 87340 | <1% | 16 | $90.84 | |
| 82374 | <1% | 103 | $84.23 | |
| 81025 | <1% | 14 | $25.81 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 51 | $0.00 |
| 99050 | 0% | 29 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRUIZ, CARLOS (VICE PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Core Analytics Radiology, LLC | Van Nuys, CA | $3.26M |
| Carlos E Ruiz Rodriguez MD LLC | San Juan, PR | $57K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.